BRIEF-Astera Labs Inc Sees IPO Of 17.8 Million Shares - Filing-March 2024-www.financetom.com

BRIEF-Astera Labs Inc Sees IPO Of 17.8 Million Shares - Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Astera Labs Inc Sees IPO Of 17.8 Million Shares - Filing

Mar 8, 2024 3:54 AM

March 8 (Reuters) - Astera Labs Inc :

* ASTERA LABS INC SEES IPO OF 17.8 MILLION SHARES - FILING

* ASTERA LABS INC SAYS IPO PRICE TO BE BETWEEN $27 & $30 PER

* ASTERA LABS INC ADDS LOOP CAPITAL MARKETS, SIEBERT

WILLIAMS

SHANK AS UNDERWRITERS TO IPO

* ASTERA LABS INC SEES CO OFFERING 14.8 MILLION SHARES OF

COMMON

STOCK AND SELLING STOCKHOLDERS OFFERING 3.0 MILLION SHARES

Source text for Eikon:

Further company coverage:

Previous page： Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism Next page： --McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism

Apr 24, 2024

11:33 AM EDT, 04/24/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Wednesday that the UK's Medicines and Healthcare Products Regulatory Agency has granted marketing authorization for Yorvipath as a parathyroid hormone, or PTH, replacement therapy to treat adults with chronic hypoparathyroidism. The UK regulator also granted orphan drug status to Yorvipath, or palopegteriparatide, providing 10 years of market...

--McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3

Apr 24, 2024

11:30 AM EDT, 04/24/2024 (MT Newswires) -- Price: 530.68, Change: -1.32, Percent Change: -0.25 ...

Moderna to Collaborate With OpenAI to Launch New Generation of Medicines

Apr 24, 2024

11:36 AM EDT, 04/24/2024 (MT Newswires) -- Moderna ( MRNA ) and OpenAI said Wednesday they will continue to collaborate to launch a new generation of medicines. The drugmaker and Microsoft ( MSFT )-backed (MSFT) OpenAI started their collaboration in early 2023 with the launch of Moderna's ( MRNA ) own instance of ChatGPT, called mChat. Moderna ( MRNA )...

Caltech resolves lawsuit against HP over Wi-Fi patents

Apr 24, 2024

April 24 (Reuters) - The California Institute of Technology has agreed to drop its lawsuit accusing HP Inc ( HPQ ) of infringing patents related to wireless communications, according to a filing in Texas federal court. Caltech and HP told the U.S. District Court for the Western District of Texas on Tuesday that they would dismiss the case with prejudice,...